by admin | Nov 23, 2023 | News & Opinions
By Mayo Clinic’s Discovery’s Edge Mayo Clinic researchers and collaborators have identified a protein expressed by immune cells that may play a key role in the development of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease....
by admin | Nov 22, 2023 | News & Opinions
By Gina Kolata – The New York Times The first treatment that relies on CRISPR is expected to receive U.S. approval next month. But it may cost millions of dollars per patient. Regulators in Britain on Thursday approved the first treatment derived from CRISPR, the...
by admin | Nov 21, 2023 | News & Opinions
By News Medical Life Sciences Researchers from the Critical Analytics for Manufacturing Personalized-Medicine (CAMP) Interdisciplinary Research Group (IRG) of Singapore-MIT Alliance for Research and Technology (SMART), MIT’s research enterprise in Singapore, in...
by admin | Nov 16, 2023 | News & Opinions
By Andrew Schulman – Technology Networks Why do we need allogeneic therapies when autologous therapies have enjoyed such success? The lessons learned from the development and manufacture of autologous cell therapies are helping lay a solid groundwork for the...
by admin | Nov 15, 2023 | News & Opinions, Video
By Carrie Cochran and Catie Beck – Scripps News and ProPublica Forrest VanPatten was diagnosed with an aggressive form of lymphoma, but his insurance company denied coverage for a clinically proven treatment. in July 2019. That same month, he turned 50 years...
